-
Chronic hypertension and adverse pregnancy outcomes: a cohort study.
Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:228-235. pdf -
Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:203-9. pdf -
Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valino N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016;47:194-202. pdf -
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.
Bujold E, Roberge S, Nicolaides KH.
Prenat Diagn 2014;34:642-8. pdf -
Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes.
Poon LC, Musci T, Song K, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2013;33:215-23. pdf -
Maternal age and adverse pregnancy outcomes: a cohort study.
Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH.
Ultrasound Obstet Gynecol 2013;42:634-43. pdf -
Body Mass Index at 11-13 Weeks' Gestation and Pregnancy Complications.
Syngelaki A, Bredaki FE, Vaikousi E, Maiz N, Nicolaides KH.
Fetal Diagn Ther 2011;30:250-65. -
First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.
Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH.
Prenat Diagn 2009;29:553-9. -
First-trimester maternal serum a disintegrin and metalloprotease 12 (ADAM12) and adverse pregnancy outcome.
Poon LC, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH.
Obstet Gynecol 2008;112:1082-90. -
Some thoughts on the true value of ultrasound.
Nicolaides KH.
Ultrasound Obstet Gynecol 2007;30:671-4. -
Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor.
Tsoi E, Akmal S, Geerts L, Jeffery B, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:368-72. -
Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study.
To MS, Skentou CA, Royston P, Yu CK, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:362-7. -
Maternal characteristics and cervical length in the prediction of spontaneous early preterm delivery in twins.
To MS, Fonseca EB, Molina FS, Cacho AM, Nicolaides KH.
Am J Obstet Gynecol 2006;194:1360-5. -
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction.
Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH.
Am J Obstet Gynecol 2006;195:1668-73. -
Preterm birth: the value of sonographic measurement of cervical length.
Kagan K, To M, Tsoi E, Nicolaides K.
BJOG 2006;113:52-56. -
Relationship between second-trimester uterine artery Doppler and spontaneous early preterm delivery.
Fonseca E, Yu CK, Singh M, Papageorghiou AT, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:301-5. -
Fetal growth restriction and postnatal development.
Eleftheriades M, Creatsas G, Nicolaides K.
Ann N Y Acad Sci 2006;1092:319-30. -
Maternal cardiac function in fetal growth restriction.
Bamfo JE, Kametas NA, Turan O, Khaw A, Nicolaides KH.
BJOG 2006;113:784-91. -
One-stage screening for pregnancy complications by color doppler assessment of the uterine arteries at 23 weeks' gestation.
Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH.
Obstet Gynecol 2000;96:559-64. -
Preterm delivery and growth restriction in multifetal pregnancies reduced to twins.
Sebire NJ, Sherod C, Abbas A, Snijders RJ, Nicolaides KH.
Hum Reprod 1997;12:173-5.